Acorda Therapeutics Inc (NASDAQ:ACOR)

23.70
Delayed Data
As of May 18
 -0.45 / -1.86%
Today’s Change
13.60
Today|||52-Week Range
29.60
+10.49%
Year-to-Date
No recent news for Acorda Therapeutics Inc.

Today’s Trading

Previous close24.15
Today’s open24.20
Day’s range23.45 - 24.20
Volume396,733
Average volume (3 months)555,963
Market cap$1.2B
Data as of 4:00pm ET, 05/18/2018

Growth & Valuation

Earnings growth (last year)-539.47%
Earnings growth (this year)-129.06%
Earnings growth (next 5 years)+29.00%
Revenue growth (last year)+13.22%
P/E ratioNM
Price/Sales1.68
Price/Book2.21

Competitors

 Today’s
change
Today’s
% change
HRTXHeron Therapeutics I...-0.70-2.10%
ZIOPZIOPHARM Oncology In...+0.02+0.45%
ATNXAthenex Inc0.000.00%
BYSIBeyondspring Inc-0.23-0.83%
Data as of 4:00pm ET, 05/18/2018

Financials

Next reporting dateAugust 2, 2018
EPS forecast (this quarter)$0.68
Annual revenue (last year)$588.3M
Annual profit (last year)-$223.4M
Net profit margin-37.97%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ronald Cohen
Chief Scientific Officer
Andrew R. Blight
Corporate headquarters
Ardsley, New York

Forecasts